Vancomycin Levels in Patients with Clostridium difficile Infection
Author Information
Author(s): Gonzales Milagros, Pepin Jacques, Frost Eric H, Carrier Julie C, Sirard Stephanie, Fortier Louis-Charles, Valiquette Louis
Primary Institution: Université de Sherbrooke
Hypothesis
To determine how faecal levels of vancomycin vary according to diarrhoea severity and dosage.
Conclusion
Faecal levels of vancomycin are proportional to the dosage administered and can be low during the first day of treatment with the standard dosage.
Supporting Evidence
- Patients with higher stool frequency had lower faecal vancomycin levels.
- Higher doses of vancomycin led to significantly higher faecal levels.
- Faecal levels were consistently higher than the MIC90 of vancomycin against C. difficile.
Takeaway
This study looked at how much vancomycin gets into poop when people take it for a bad stomach bug. It found that taking more medicine means more gets into the poop.
Methodology
A prospective observational study where faeces were collected from hospitalized adults receiving different dosages of oral vancomycin.
Potential Biases
Inclusion of patients without confirmed CDI may introduce bias in the results.
Limitations
The small sample size limited the power to detect significant differences, and some patients were not confirmed to have CDI.
Participant Demographics
Median age of participants was 63 years, with 9 women and 6 men.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website